insights_auto
Why is INO down 2.10%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
$1.40
arrow_downward
-2.10%(-0.030) 1D
$1.39
arrow_downward
-0.71% (-0.0100)bedtimeAfter hours
Closed: Nov 16, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
$1.42
High
$1.48
Low
$1.37
Mkt. cap
262.23M
Avg. vol.
19.34M
Volume
6.63M
52-wk high
$2.72
52-wk low
$0.57
EPS
-$0.80
Beta
1.71
Shares outstanding
187.31M
No. of employees
112
Open
$1.42
High
$1.48
Low
$1.37
Mkt. cap
262.23M
Avg. vol.
19.34M
Volume
6.63M
52-wk high
$2.72
52-wk low
$0.57
EPS
-$0.80
Beta
1.71
Shares outstanding
187.31M
No. of employees
112
News stories
From web sources and news partners
Stocktwits
·
1 hour ago
S&P 500, Dow, Nasdaq End Lower As Investors Hold Back Ahead Of Nvidia Earnings, Anthropic IPO This Week — NVDA, TSLA, ANT In Focus
ChartMill
·
5 hours ago
S&P 500 Top Movers: Gainers and Losers for Nov. 16, 2026
BigGo Finance
·
11 hours ago
Bitget Opens Onchain Yield Vaults for Tokenized S&P 500, Nasdaq-100 Trackers
Traders Union
·
55 minutes ago
Airline shares post double-digit gains while S&P 500 falls, Phil Rosen notes
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc
CEOJacqueline Shea
Employees112
Founded1999
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteinovio.com